DeVito, N., Sturdivant, M., Wachsmuth, L., Strickler, J., Beasley, G., Al-Rohil, R., … Hanks, B. (2020). 425 Investigation of Wnt ligand signaling regulators as a predictor of Anti-PD-1 response in metastatic melanoma. In Regular and young investigator award abstracts (pp. A258–A259). BMJ Publishing Group Ltd. https://doi.org/10.1136/jitc-2020-sitc2020.0425

DeVito, Nicholas, Michael Sturdivant, Luke Wachsmuth, John Strickler, Georgia Beasley, Rami Al-Rohil, April Salama, and Brent Hanks. “425 Investigation of Wnt ligand signaling regulators as a predictor of Anti-PD-1 response in metastatic melanoma.” In Regular and Young Investigator Award Abstracts, A258–59. BMJ Publishing Group Ltd, 2020. https://doi.org/10.1136/jitc-2020-sitc2020.0425.

DeVito N, Sturdivant M, Wachsmuth L, Strickler J, Beasley G, Al-Rohil R, et al. 425 Investigation of Wnt ligand signaling regulators as a predictor of Anti-PD-1 response in metastatic melanoma. In: Regular and young investigator award abstracts. BMJ Publishing Group Ltd; 2020. p. A258–9.

DeVito, Nicholas, et al. “425 Investigation of Wnt ligand signaling regulators as a predictor of Anti-PD-1 response in metastatic melanoma.” Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd, 2020, pp. A258–59. Crossref, doi:10.1136/jitc-2020-sitc2020.0425.

DeVito N, Sturdivant M, Wachsmuth L, Strickler J, Beasley G, Al-Rohil R, Salama A, Hanks B. 425 Investigation of Wnt ligand signaling regulators as a predictor of Anti-PD-1 response in metastatic melanoma. Regular and young investigator award abstracts. BMJ Publishing Group Ltd; 2020. p. A258–A259.